Other names: ARHI; NOEY2; RHOI HGNC (Hugo): DIRAS3 Location: 1p31.3 Local order: Telomeric to GNG12, RMU7-80P and centromeric to GPR177, RPS7P4. Note: DIRAS3 is also known as NOEY2 and ARHI (Ras homologue member I).
DNA/RNA
Description DIRAS3 encompasses a 7.2-kb region and includes 2.0 kb of the 5'-flanking region, two exons, an intron, and a 1.2-kb 3'-flanking region. The first exon contains only the 5'-noncoding region consisting of 81 nucleotides, whereas the second exon contains the entire protein-coding region. The two exons are separated by an intron of 3.2 kb. There are three CpG island regions. CPG island I (nucleotide (nt) -1232 to -914) is located about 1 kb upstream of the transcription initiation site; CpG island II (nt -206 to +79) is near the transcription initiation region and adjacent exon 1; CpG island III (nt +3343 to +3691) is located in the protein-encoding region of exon 2.
Transcription
The entire protein-coding region is located within exon 2 and encodes a 229-residue small GTP-binding protein.
Pseudogene
No known pseudogenes.
The DIRAS3 gene contains two exons interrupted by a large intron. The red-blocked and opened boxes represent the coding and noncoding regions, respectively. There are three CpG island regions. Blue: CPG island I; green: CpG island II; grey: CpG island III. Yu Y, et al. Atlas Genet Cytogenet Oncol Haematol. 2010; 14(8) 
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DIRAS3 protein.
Protein
Description DIRAS3 encodes a 26-kDa GTPase. The DIRAS3 gene ORF contains three motifs typical of Ras/Rap family members: (1) a highly conserved GTP binding domain, (2) a putative effector domain YLPTIENTY, and (3) the membrane localizing CAAX motif at the COOH terminus. DIRAS3 contains a unique 34 amino-acid extension at the N-terminus and differs from other members of Ras-superfamily.
Expression
DIRAS3 is expressed in brain, heart, liver, lung, pancreas, breast and ovary.
Localisation
DIRAS is associated at the cell membrane through its prenylation at the C-terminal cysteine residue. Mutation of the conserved CAAX box at the Cterminus led to a loss of its membrane association.
Function
DIRAS3 is a maternally imprinted tumor suppressor gene that belongs to the Ras superfamily of small G proteins. DIRAS3 regulates cell cycle, motility, angiogenesis, autophagy and tumor dormancy. Introduction of this gene into cancer cells that lack DIRAS3 expression inhibits proliferation and motility of cancer cells. DIRAS3 truncates signaling through the Ras/MAP pathway, induces p21 WAF1/CIP1 , downregulates cyclin D1, and triggers apoptosis. DIRAS3 is required for autophagy and that re-expression of DIRAS3 protein in ovarian cancer cells will induce autophagic cell death in culture. In xenografts, reexpression of DIRAS3 also induces autophagy, but can also promote tumor dormancy in the presence of factors that promote survival in the cancer microenvironment.
Homology
DIRAS3 shares 56% amino acid homology with Rap1A, 56% with Rap1B, 58% with Rap 2A, 62% with Rap2B, 59% with K-Ras, and 54% with H-Ras. DIRAS3 shares about 40% homology with DIRAS1 and DIRAS2.
Mutations
Note
Mutations have not been detected.
Implicated in
Solid cancers
Disease Ovarian cancer, breast cancer, pancreatic cancer, hepatocellular carcinoma, oligodendroglial tumor, follicular thyroid cancer. Prognosis Loss of DIRAS3 expression is associated with tumor progression in breast cancer and decreased disease-free survival in ovarian cancer. Oncogenesis DIRAS3 is monoallelically expressed and maternally imprinted, expression from the paternal allele of DIRAS3 can be lost through LOH, CpG methylation, and transcriptional regulation. DIRAS3 is downregulated in 60% of ovarian and breast cancers: LOH was found in 40% of ovarian and breast cancers. Mutations have not been detected, but the remaining allele is silenced in ovarian cancer and breast cancer by methylation in approximately 10-15% of cases. In the remaining cancers, DIRAS3 is downregulated by transcriptional mechanisms that involve E2F1 and E2F4, as well as by the loss of RNA binding proteins that decrease the half-life of DIRAS3 mRNA.
